The initiation of #tirzepatide therapy significantly decreases the incidence of myocardial infarction and all-cause mortality among high-risk individuals with type 2 #diabetes. https://www.endocrinologyadvisor.com/news/tirzepatide-mace-risk-type-2-diabetes-ascvd/
Tirzepatide Reduces Cardiovascular Events in Type 2 Diabetes
Tirzepatide therapy reduces the risk for major adverse cardiovascular events in patients with type 2 diabetes and established CVD.
endocrinologyadvisor.com